A groundbreaking study reveals that innovative blood tests may detect cancer years before diagnosis. With the potential to change cancer treatment, learn how these tests could save lives in the future.
Colorectal cancer screening is evolving with the fecal immunochemical test (FIT), a non-invasive alternative to colonoscopy. Discover how FIT works and its benefits for younger adults seeking early detection.
Billy Evans, partner of Theranos founder Elizabeth Holmes, unveils Haemanthus, a startup aiming to revolutionize health optimization through advanced blood testing. With ambitions to raise over $50 million, this venture echoes Theranos' controversial legacy. Is it a groundbreaking innovation or a repeat of past mistakes?
A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
